リープ・セラピューティクスのニュース一覧

ロバート・W・ベアードはリープ セラピューティクス(LPTX.US)のレーティングを強気に据え置き、目標株価を9ドルに据え置いた

Futuニュース08/13 22:31

Leap Therapeutics Price Target Maintained With a $5.50/Share by HC Wainwright & Co.

Dow Jones08/13 19:20

Leap Therapeutics Analyst Ratings

Benzinga08/13 19:13

H.C. Wainwrightはリープ セラピューティクス(LPTX.US)のレーティングを強気に据え置き、目標株価を5.5ドルに据え置いた

Futuニュース08/13 18:31

Leap Therapeutics: Runway To Fund Operating, Capital Spending Into 2Q 2026 >LPTX

Dow Jones08/12 19:06

Leap Therapeutics Analyst Ratings

Benzinga06/29 00:47

Rodman & Renshaw Initiates Coverage On Leap Therapeutics With Buy Rating, Announces Price Target of $8

Benzinga06/29 00:47

Leap Therapeutics Analyst Ratings

Benzinga05/14 19:50

HC Wainwright & Co. Maintains Buy on Leap Therapeutics, Lowers Price Target to $5.5

Benzinga05/14 19:50

Baird Adjusts Price Target on Leap Therapeutics to $9 From $11, Maintains Outperform Rating

MT Newswires03/19 21:30

Baird Maintains Outperform on Leap Therapeutics, Lowers Price Target to $9

Benzinga03/19 19:10

Leap Therapeutics Analyst Ratings

Benzinga03/19 18:50

HC Wainwright & Co. Reiterates Buy on Leap Therapeutics, Maintains $7 Price Target

Benzinga03/19 18:50

Leap Therapeutics Analyst Ratings

Benzinga2023/11/20 23:38

Raymond James Maintains Outperform on Leap Therapeutics, Lowers Price Target to $17.5

Benzinga2023/11/14 16:42

Leap Therapeutics Analyst Ratings

Benzinga2023/11/14 16:41

HC Wainwright & Co. Maintains Buy on Leap Therapeutics, Raises Price Target to $7

Benzinga2023/08/15 18:50

Leap Therapeutics Analyst Ratings

Benzinga2023/08/15 18:49

Raymond James Adjusts Price Target on Leap Therapeutics to $18.50 From $17, Maintains Outperform Rating

MT Newswires2023/07/13 19:10

Raymond James Maintains Outperform on Leap Therapeutics, Raises Price Target to $18.5

Benzinga2023/07/13 16:38